These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

829 related items for PubMed ID: 25398058

  • 1. Extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae bacteremia in febrile neutropenic children.
    Han SB, Jung SW, Bae EY, Lee JW, Lee DG, Chung NG, Jeong DC, Cho B, Kang JH, Kim HK, Park YJ.
    Microb Drug Resist; 2015 Apr; 21(2):244-51. PubMed ID: 25398058
    [Abstract] [Full Text] [Related]

  • 2. Laboratory identification, risk factors, and clinical outcomes of patients with bacteremia due to Escherichia coli and Klebsiella pneumoniae producing extended-spectrum and AmpC type β-lactamases.
    Tsui K, Wong SS, Lin LC, Tsai CR, Chen LC, Huang CH.
    J Microbiol Immunol Infect; 2012 Jun; 45(3):193-9. PubMed ID: 22580086
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Control of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a children's hospital by changing antimicrobial agent usage policy.
    Lee J, Pai H, Kim YK, Kim NH, Eun BW, Kang HJ, Park KH, Choi EH, Shin HY, Kim EC, Lee HJ, Ahn HS.
    J Antimicrob Chemother; 2007 Sep; 60(3):629-37. PubMed ID: 17599919
    [Abstract] [Full Text] [Related]

  • 7. Aminoglycoside therapy for childhood urinary tract infection due to extended-spectrum β-lactamase-producing Escherichia coli or Klebsiella pneumoniae.
    Han SB, Lee SC, Lee SY, Jeong DC, Kang JH.
    BMC Infect Dis; 2015 Oct 13; 15():414. PubMed ID: 26464143
    [Abstract] [Full Text] [Related]

  • 8. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital.
    Kader AA, Kumar A.
    Ann Saudi Med; 2005 Oct 13; 25(3):239-42. PubMed ID: 16119526
    [Abstract] [Full Text] [Related]

  • 9. Bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Antimicrob Agents Chemother; 2004 Dec 13; 48(12):4574-81. PubMed ID: 15561828
    [Abstract] [Full Text] [Related]

  • 10. Antimicrobial susceptibility of clinical Enterobacteriaceae isolates at the emergency department in a regional hospital: A threat of extended spectrum beta-lactamase-producers among nursing home residents.
    Liu HC, Hung YP, Lin HJ, Liu HC, Lee JC, Wu YH, Li CW, Li MC, Ko WC.
    J Microbiol Immunol Infect; 2016 Aug 13; 49(4):584-90. PubMed ID: 26692184
    [Abstract] [Full Text] [Related]

  • 11. Phenotypic confirmation of extended-spectrum B-lactamases (ESBL) in clinical isolates of Escherichia coli and Klebsiella pneumoniae at the San Juan Veterans Affairs Medical Center.
    Del Carmen Rodríguez M, Vera DE, Ramírez-Ronda CH, Saavedra S.
    P R Health Sci J; 2004 Sep 13; 23(3):207-15. PubMed ID: 15631176
    [Abstract] [Full Text] [Related]

  • 12. Appropriate non-carbapenems are not inferior to carbapenems as initial empirical therapy for bacteremia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a propensity score weighted multicenter cohort study.
    Ko JH, Lee NR, Joo EJ, Moon SY, Choi JK, Park DA, Peck KR.
    Eur J Clin Microbiol Infect Dis; 2018 Feb 13; 37(2):305-311. PubMed ID: 29177611
    [Abstract] [Full Text] [Related]

  • 13. Carbapenem therapy is associated with improved survival compared with piperacillin-tazobactam for patients with extended-spectrum β-lactamase bacteremia.
    Tamma PD, Han JH, Rock C, Harris AD, Lautenbach E, Hsu AJ, Avdic E, Cosgrove SE, Antibacterial Resistance Leadership Group.
    Clin Infect Dis; 2015 May 01; 60(9):1319-25. PubMed ID: 25586681
    [Abstract] [Full Text] [Related]

  • 14. Antibacterial susceptibility of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Bishara J, Livne G, Ashkenazi S, Levy I, Pitlik S, Ofir O, Lev B, Samra Z.
    Isr Med Assoc J; 2005 May 01; 7(5):298-301. PubMed ID: 15909461
    [Abstract] [Full Text] [Related]

  • 15. Pediatric extended spectrum β-lactamase infection: Community-acquired infection and treatment options.
    Sethaphanich N, Santanirand P, Rattanasiri S, Techasaensiri C, Chaisavaneeyakorn S, Apiwattanakul N.
    Pediatr Int; 2016 May 01; 58(5):338-46. PubMed ID: 26513341
    [Abstract] [Full Text] [Related]

  • 16. Bacteremia due to extended-spectrum beta -lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge.
    Rodríguez-Baño J, Navarro MD, Romero L, Muniain MA, de Cueto M, Ríos MJ, Hernández JR, Pascual A.
    Clin Infect Dis; 2006 Dec 01; 43(11):1407-14. PubMed ID: 17083012
    [Abstract] [Full Text] [Related]

  • 17. Prevalence and antimicrobial resistance patterns of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolated from blood cultures in an Istanbul University Hospital.
    Koksal F, Ak K, Kucukbasmaci O, Samasti M.
    Chemotherapy; 2009 Dec 01; 55(4):293-7. PubMed ID: 19521075
    [Abstract] [Full Text] [Related]

  • 18. Association of antibiotic utilization measures and reduced incidence of infections with extended-spectrum beta-lactamase-producing organisms.
    Lan CK, Hsueh PR, Wong WW, Fung CP, Lau YT, Yeung JY, Young GT, Su CC.
    J Microbiol Immunol Infect; 2003 Sep 01; 36(3):182-6. PubMed ID: 14582562
    [Abstract] [Full Text] [Related]

  • 19. Use of cefepime for the treatment of infections caused by extended spectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli.
    Labombardi VJ, Rojtman A, Tran K.
    Diagn Microbiol Infect Dis; 2006 Nov 01; 56(3):313-5. PubMed ID: 17084784
    [Abstract] [Full Text] [Related]

  • 20. Extended-spectrum beta-lactamase-producing phenotype signifies a poor prognosis for patients with cefpodoxime-resistant Escherichia coli or Klebsiella pneumoniae bacteremia.
    Lee CI, Lee NY, Yan JJ, Lee HC, Ko NY, Chang CM, Wu CJ, Chen PL, Wang LR, Ko WC.
    J Microbiol Immunol Infect; 2009 Aug 01; 42(4):303-9. PubMed ID: 19949753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.